Kinetic Medical(SZ:300326) Ge Long Hui·2025-11-21 09:44Core Viewpoint - ST Kelly plans to invest in Dongzhi Medical Technology (Shanghai) Co., Ltd. through equity transfer and subscription of newly registered capital to meet future strategic development needs [1] Company Summary - Dongzhi Medical is focused on the research, production, and sales of regenerative induction products, including regenerative induction biological patches, active cell patches, umbilical cord stem cell preparations, and amniotic membrane gel dressings [1] - The registered capital of Dongzhi Medical is 1.783679 million yuan [1] - Currently, ST Kelly holds 37.9528% of Dongzhi Medical's equity, corresponding to a registered capital of 676,957 yuan [1] Investment Details - As part of the investment, shareholders Shanghai Lisai Management Consulting Partnership (Limited Partnership) and Yuan Zheng will exit Dongzhi Medical [1] - ST Kelly agrees to acquire the equity held by Lisai Management and Yuan Zheng, and will also increase the capital of Dongzhi Medical [1]